BRIEF-Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya

Reuters11-04

Nov 4 (Reuters) - Tonix Pharmaceuticals Holding Corp

* TONIX PHARMACEUTICALS ANNOUNCES RESEARCH AGREEMENT WITH KENYA MEDICAL RESEARCH INSTITUTE (KEMRI) TO DESIGN, PLAN AND SEEK REGULATORY APPROVAL FOR A PHASE I CLINICAL STUDY OF TNX-801 FOR MPOX IN KENYA

* TONIX PHARMACEUTICALS HOLDING CORP - TO TEST TNX-801 VACCINE FOR MPOX IN KENYA

* TONIX PHARMACEUTICALS HOLDING CORP - TO SPONSOR, KEMRI TO LEAD CLINICAL TRIAL FOR TNX-801

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2480558747?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-04 23:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2480558747","market":"us","top_or_hot":-1,"title":"BRIEF-Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya","media":"Reuters","content":"<html><body><p>Nov 4 (Reuters) - Tonix Pharmaceuticals Holding Corp</p><p> :</p><p>   * TONIX PHARMACEUTICALS ANNOUNCES RESEARCH AGREEMENT WITH KENYA MEDICAL RESEARCH INSTITUTE (KEMRI) TO DESIGN, PLAN AND SEEK REGULATORY APPROVAL FOR A PHASE I CLINICAL STUDY OF TNX-801 FOR MPOX IN KENYA</p><p>   * TONIX PHARMACEUTICALS HOLDING CORP - TO TEST TNX-801 VACCINE FOR MPOX IN KENYA</p><p>   * TONIX PHARMACEUTICALS HOLDING CORP - TO SPONSOR, KEMRI TO LEAD CLINICAL TRIAL FOR TNX-801</p><p>Source text:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-04 23:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 4 (Reuters) - Tonix Pharmaceuticals Holding Corp :   * TONIX PHARMACEUTICALS ANNOUNCES RESEARCH AGREEMENT WITH KENYA MEDICAL RESEARCH INSTITUTE (KEMRI) TO DESIGN, PLAN AND SEEK REGULATORY APPROVAL...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNXP","symbol_name":"Tonix Pharmaceuticals Holding Co","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2480558747","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2480558747","pubTimestamp":1730734407,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 4  - Tonix Pharmaceuticals Holding Corp :   * TONIX PHARMACEUTICALS ANNOUNCES RESEARCH AGREEMENT WITH KENYA MEDICAL RESEARCH INSTITUTE  TO DESIGN, PLAN AND SEEK REGULATORY APPROVAL FOR A PHASE I CLINICAL STUDY OF TNX-801 FOR MPOX IN KENYA   * TONIX PHARMACEUTICALS HOLDING CORP - TO TEST TNX-801 VACCINE FOR MPOX IN KENYA   * TONIX PHARMACEUTICALS HOLDING CORP - TO SPONSOR, KEMRI TO LEAD CLINICAL TRIAL FOR TNX-801Source text:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNXP":"Tonix Pharmaceuticals Holding Co","BK4139":"生物科技","BK4583":"猴痘概念"},"translate_title":"简介-Tonix Pharmaceuticals和肯尼亚医学研究所将在肯尼亚设计、规划并寻求监管部门批准TNX-801治疗Mpox的I期临床研究","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNXP":1},"content_text":"Nov 4 (Reuters) - Tonix Pharmaceuticals Holding Corp :   * TONIX PHARMACEUTICALS ANNOUNCES RESEARCH AGREEMENT WITH KENYA MEDICAL RESEARCH INSTITUTE (KEMRI) TO DESIGN, PLAN AND SEEK REGULATORY APPROVAL FOR A PHASE I CLINICAL STUDY OF TNX-801 FOR MPOX IN KENYA   * TONIX PHARMACEUTICALS HOLDING CORP - TO TEST TNX-801 VACCINE FOR MPOX IN KENYA   * TONIX PHARMACEUTICALS HOLDING CORP - TO SPONSOR, KEMRI TO LEAD CLINICAL TRIAL FOR TNX-801Source text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2480558747"}